Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Sebaceous Cell Tumor of Eyelid 1Prostatic Neoplasms 1Prostate cancer, familial 1Neuroma, Acoustic 1Neurofibromatosis 2 1Lung Squamous Cell Carcinoma 1Genetic Predisposition to Disease 1Breast Neoplasms 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 31Pemetrexed 28Radiotherapy 22Bevacizumab 21Cisplatin 20Gemcitabine 18Paclitaxel 17Erlotinib Hydrochloride 15Docetaxel 12Gefitinib 8Nivolumab 6Mastectomy, Segmental 6Magnetic Resonance Spectroscopy 6pembrolizumab 5aflutinib 5Radiosurgery 5tislelizumab 4Vinorelbine 4Surgical Procedures, Operative 4Specimen Handling 4Sorafenib 4Platinum 4Metformin 4Biopsy 42-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 4sargramostim 3apatinib 3Taxes 3Cetuximab 3Anterior Temporal Lobectomy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Adenocarcinoma of Lung × Exome × Clear all
NCT06215885 2024-09-24

Multi-omics Analysis to Characterize the Invasive Evolution of Pulmonary Subsolid Nodules

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Unknown
220 enrolled
Thoracic

Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡